サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1577565

近視・老眼治療の世界市場

Myopia and Presbyopia Treatment

出版日
ページ情報
英文 189 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
近視・老眼治療の世界市場
出版日: 2024年10月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

近視・老眼治療の世界市場は2030年までに263億米ドルに達する見込み

2023年に175億米ドルと推定された近視・老眼治療の世界市場は、2023年から2030年にかけてCAGR 6.0%で成長し、2030年には263億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである近視治療は、CAGR 6.3%を記録し、分析期間終了時には161億米ドルに達すると予測されます。老眼治療セグメントの成長率は、分析期間中CAGR 5.6%と推定されます。

米国市場は48億米ドルと推定、中国はCAGR9.7％で成長予測

米国の近視・老眼治療市場は2023年に48億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR 9.7％を引きずる形で、2030年までに予測市場規模56億米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5%と6.1%と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の近視・老眼治療市場- 主要動向と促進要因まとめ

近視・老眼治療が世界的に重要性を増しているのはなぜか？

近視・老眼治療は、人口動態の変化、ライフスタイルの変化、高齢化などにより、これらの屈折性視力障害の有病率が急速に上昇しているため、世界的に重要性を増しています。近視は世界的に最も一般的な視力障害の1つであり、何百万人もの人々、特に若年層に影響を及ぼしています。近視の有病率は、読書、スクリーン使用、デジタル機器など、近くを見る活動に費やす時間の増加により、特に都市化した地域で急速に増加しています。近視の罹患率の増加により、網膜剥離、白内障、緑内障などの疾患の発症リスクが高くなるなど、長期的な合併症の可能性が懸念されています。このため、近視の早期発見と治療は眼科において重要な焦点となっています。

一方、老眼は加齢に関連した症状であり、40歳以上のほぼ全員が罹患します。世界人口の高齢化に伴い、老眼の効果的な治療に対する需要は増加の一途をたどっています。老眼は、近くのものに焦点を合わせる目の能力を低下させるため、老眼鏡、コンタクトレンズ、遠近両用メガネなどの矯正レンズが広く使用されるようになります。しかし、医療技術の進歩により、多焦点レンズ、屈折矯正手術、革新的なデザインのコンタクトレンズなど、新たな治療オプションが登場しています。目の健康が重視されるようになり、メガネのような一時的な治療ではなく、長期的な解決策を提供する治療への需要が高まっていることが、より高度な治療の開発を後押ししています。近視は世界の多くの地域で流行し、老眼は高齢化社会に影響を及ぼしているため、高度で利用しやすい治療へのニーズはかつてないほど高まっています。

技術の進歩は近視・老眼治療にどのような革命をもたらしているのでしょうか？

技術の進歩は近視・老眼治療状況を一変させ、以前よりも効果的で長持ちし、侵襲性の低い解決策を提供しています。近視の場合、最も重要な進歩のひとつはオルソケラトロジー（オルソK）レンズの開発です。オルソケラトロジー（オルソK）レンズは、一晩で角膜の形を変え、一時的に視力を矯正する特別にデザインされたコンタクトレンズです。この非侵襲的な方法は、進行性近視の子供や若年成人にとって効果的な治療法であることが証明されており、症状の悪化を遅らせるのに役立っています。さらに、低用量アトロピン点眼薬は、小児の近視進行を抑制する有望な薬理学的治療法として登場しました。眼球の伸長を遅らせることで、これらの治療は、後年より深刻な眼の健康問題につながる可能性のある強度近視のリスクを減らすことを目的としています。

老眼については、レンズ技術と手術技術の進歩により、治療の選択肢が変わりつつあります。白内障手術で使用される多焦点眼内レンズや焦点深度拡大眼内レンズが老眼矯正に使用されることが多くなり、眼鏡を必要とせずに複数の距離を見ることができるようになりました。さらに、多焦点レンズや遠近両用レンズを含む老眼矯正用コンタクトレンズは、レンズの素材やデザインの革新により、視覚の明瞭さと装用感が向上し、より快適で効果的なものになってきています。レーシックや角膜インレーなどの手術治療も、角膜の形を整えたり、近見視力を改善する装置を挿入することで、長期的な解決策を提供しています。これらの最先端治療は、患者に柔軟性とより永続的な解決策を提供し、眼鏡への依存を減らし、生活の質を向上させています。

さらに、デジタルヘルス技術と人工知能（AI）の台頭は、治療戦略をさらに強化しています。AI主導の診断ツールは、近視の進行や老眼の初期兆候を検出するために使用されており、よりタイムリーで的を絞った介入を可能にしています。遠隔医療プラットフォームもまた、特に従来の眼科医療サービスが制限されるような遠隔地や十分なサービスを受けていない地域での医療へのアクセス改善に役立っています。このような技術的進歩は、利用可能な治療の選択肢を広げるだけでなく、眼科治療をより個別化、効率化し、利用しやすくしています。

患者の嗜好の変化は近視・老眼治療市場をどのように形成しているか？

特に利便性、審美性、ライフスタイルに関する患者の嗜好の変化は、近視・老眼治療市場の形成に重要な役割を果たしています。人々が快適さとライフスタイルへの適応性を優先する時代において、多くの患者は活動的なライフスタイルに合致し、眼鏡のような従来の矯正手段への依存を減らす治療ソリューションを求めています。近視の場合、標準的な矯正レンズ以上の治療に対する需要が高まっています。オルソケラトロジー（Ortho-K）レンズや低用量アトロピン点眼薬など、近視の進行を遅らせることができ、後年、より強い処方を必要とする可能性を減らすことができる、予防的治療を子供に求める親が増えています。眼鏡の必要性を減らしたりなくしたりできることは、眼鏡が煩わしいスポーツやその他の活動に従事している子供や若者にとって特に魅力的です。

老眼の場合、多くの患者が、不便で魅力的でないと思われがちな老眼鏡から、より自由になれる解決策を探しています。白内障手術で使用される多焦点コンタクトレンズや高度眼内レンズ（IOL）の人気が高まっているのは、加齢に伴う視力低下に対して、より永続的で審美的に優れた解決策を求める患者の要望によるところが大きいです。これらのレンズは、遠近両用メガネや老眼鏡を必要とせず、複数の距離でクリアな視界を得られるという利点があります。また、レーシックや角膜インレーなど、長期的な矯正が可能で、眼鏡を管理する日々の煩わしさから解放される手術オプションに対する患者の関心も高まっています。さらに、技術の進歩に伴い、多くの人々が、回復時間の短い低侵襲な治療を期待するようになり、老眼矯正のための洗練された低リスクの手術オプションの開発をさらに後押ししています。

審美的な関心もまた、患者の嗜好において重要な役割を果たしており、特に若い世代は見た目と利便性を優先しています。そのため、眼鏡をかけずにクリアな視界を得る治療への関心が高まっており、コンタクトレンズ、屈折矯正手術、革新的な点眼療法が人気を集めています。このような患者の嗜好の変化は、近視と老眼の両方に対して、より多様でカスタマイズされた、侵襲性の低い治療オプションに対する需要を促進し、これらの症状の管理方法を根本的に変革しています。

近視・老眼治療の世界市場成長の原動力は？

世界の近視・老眼治療市場の成長は、これらの視力障害の有病率の上昇、高度で低侵襲な治療に対する需要の増加、眼科医療における技術革新など、いくつかの重要な要因によって牽引されています。最も重要な成長要因の1つは、世界の近視患者の急増で、特に都市部の若年層で顕著です。スクリーン使用時間の増加、デジタル機器の使用、屋外で過ごす時間の減少などの要因が近視の蔓延に寄与しており、特にアジア太平洋では近視有病率が80%を超える地域も報告されています。このため、近視を矯正するだけでなく進行を遅らせる治療が急務となっており、オルソKレンズ、アトロピン点眼薬、高度なコンタクトレンズなどの需要が高まっています。

もう一つの重要な推進力は、世界人口の高齢化であり、これが老眼症例の増加に寄与しています。平均寿命が延びるにつれて、生活の質と自立を維持するために老眼の効果的な治療を求める人が増えています。この人口動向は、多焦点眼内レンズ（IOL）、老視矯正コンタクトレンズ、レーシックのような外科的ソリューションなどの老視矯正オプションに対する需要の急増につながっています。さらに、美容眼科やライフスタイルに基づく治療の台頭は、眼鏡を必要とせずに視力を向上させる長期的なソリューションを選ぶ個人を後押ししており、市場の成長をさらに促進しています。

近視や老眼の診断と治療における技術的進歩も大きな成長要因です。AIを搭載した診断ツール、低侵襲の手術技術、高度なレンズ設計などの革新により、治療成績が向上し、より幅広い患者がこれらの選択肢を利用しやすくなっています。さらに、遠隔医療サービスの利用可能性が高まることで、特に従来の眼科医療サービスが制限される可能性のある遠隔地や十分なサービスを受けていない地域での眼科医療へのアクセスが拡大しています。これにより、より多くの人々が専門的な治療を受けられるようになり、近視や老眼の高度な治療がさらに普及すると予想されます。

最後に、ヘルスケア支出の増加と視力の健康に関する意識の向上が市場の成長に寄与しています。政府およびヘルスケア機関は、長期的な視力障害を予防するために屈折異常の早期発見と治療の重要性を認識するようになっており、眼科医療サービスへの投資拡大や国民意識向上キャンペーンにつながっています。有病率の上昇、人口の高齢化、技術革新、ケアへのアクセスの向上といったこれらの要因が組み合わさって、世界の近視・老眼治療市場は急成長を遂げており、今後数年間で大きな拡大が見込まれます。

調査対象企業の例（全51件）

  • AbbVie, Inc.
  • Alcon, Inc.
  • Bausch & Lomb, Inc.
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • EssilorLuxottica
  • Eyenovia
  • Johnson & Johnson Vision Care, Inc.
  • LENZ Therapeutics
  • Ocuphire Pharma, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24331

Global Myopia and Presbyopia Treatment Market to Reach US$26.3 Billion by 2030

The global market for Myopia and Presbyopia Treatment estimated at US$17.5 Billion in the year 2023, is expected to reach US$26.3 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Myopia Treatment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$16.1 Billion by the end of the analysis period. Growth in the Presbyopia Treatment segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 9.7% CAGR

The Myopia and Presbyopia Treatment market in the U.S. is estimated at US$4.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Myopia and Presbyopia Treatment Market – Key Trends & Drivers Summarized

Why Is the Treatment of Myopia and Presbyopia Gaining Significance Worldwide?

The treatment of myopia and presbyopia is gaining increasing significance worldwide due to the rapid rise in the prevalence of these refractive vision disorders, largely driven by demographic shifts, lifestyle changes, and aging populations. Myopia, or nearsightedness, is one of the most common vision conditions globally, affecting millions of people, particularly younger populations. Its prevalence has been growing rapidly, especially in urbanized regions, due to increased time spent on close-up activities such as reading, screen use, and digital devices. The growing incidence of myopia has raised concerns about the potential for long-term complications, including a higher risk of developing conditions like retinal detachment, cataracts, and glaucoma. This has made the early detection and treatment of myopia a critical focus in ophthalmology.

Presbyopia, on the other hand, is an age-related condition that affects nearly everyone over the age of 40. As global populations age, the demand for effective treatments for presbyopia continues to rise. Presbyopia reduces the ability of the eye to focus on near objects, leading to the widespread use of corrective lenses such as reading glasses, contact lenses, or bifocals. However, advancements in medical technologies have led to new treatment options such as multifocal lenses, refractive surgery, and innovative contact lens designs. The growing emphasis on eye health and the demand for treatments that provide long-term solutions, rather than temporary fixes like glasses, has driven the development of more sophisticated treatments. With myopia becoming an epidemic in many parts of the world and presbyopia affecting aging populations, the need for advanced and accessible treatments is more pressing than ever.

How Are Technological Advancements Revolutionizing Myopia and Presbyopia Treatments?

Technological advancements are revolutionizing the treatment landscape for myopia and presbyopia, offering more effective, longer-lasting, and less invasive solutions than ever before. In the case of myopia, one of the most significant advancements has been the development of orthokeratology (Ortho-K) lenses, which are specially designed contact lenses that reshape the cornea overnight, temporarily correcting vision. This non-invasive method has proven to be an effective treatment for children and young adults with progressive myopia, helping to slow down the worsening of the condition. Additionally, low-dose atropine eye drops have emerged as a promising pharmacological treatment for controlling the progression of myopia in children. By slowing the elongation of the eye, these treatments aim to reduce the risk of high myopia, which can lead to more serious eye health problems later in life.

For presbyopia, advancements in lens technologies and surgical techniques are transforming treatment options. Multifocal and extended depth-of-focus intraocular lenses (IOLs) used in cataract surgery are increasingly being used to correct presbyopia, providing patients with the ability to see at multiple distances without the need for glasses. Additionally, presbyopia-correcting contact lenses, including multifocal and bifocal designs, are becoming more comfortable and effective thanks to innovations in lens materials and designs that improve visual clarity and wearer comfort. Surgical treatments, such as laser-assisted in situ keratomileusis (LASIK) and corneal inlays, are also offering long-term solutions by reshaping the cornea or inserting devices to improve near vision. These cutting-edge treatments are providing patients with greater flexibility and more permanent solutions, reducing dependence on glasses and offering enhanced quality of life.

Moreover, the rise of digital health technologies and artificial intelligence (AI) is further enhancing treatment strategies. AI-driven diagnostic tools are being used to detect early signs of myopia progression and presbyopia, enabling more timely and targeted interventions. Telemedicine platforms are also becoming instrumental in improving access to care, particularly in remote or underserved areas where traditional eye care services may be limited. These technological advancements are not only broadening the range of treatment options available but are also making eye care more personalized, efficient, and accessible.

How Are Shifting Patient Preferences Shaping the Myopia and Presbyopia Treatment Market?

Shifting patient preferences, especially regarding convenience, aesthetics, and lifestyle, are playing a crucial role in shaping the myopia and presbyopia treatment market. In an era where people prioritize comfort and lifestyle adaptability, many patients are looking for treatment solutions that align with their active lifestyles and reduce dependency on traditional corrective measures such as glasses. In the case of myopia, there is a growing demand for treatments that go beyond standard corrective lenses. Parents are increasingly seeking out preventive treatments for their children, such as orthokeratology (Ortho-K) lenses or low-dose atropine eye drops, which can slow the progression of myopia and potentially reduce the need for stronger prescriptions later in life. The ability to reduce or eliminate the need for eyeglasses is particularly appealing for children and young adults engaged in sports or other activities where glasses can be cumbersome.

For presbyopia, many patients are now looking for solutions that provide greater freedom from reading glasses, which are often seen as inconvenient or unattractive. The growing popularity of multifocal contact lenses and advanced intraocular lenses (IOLs) used in cataract surgery is largely driven by patients’ desire for a more permanent and aesthetically pleasing solution to age-related vision decline. These lenses offer the benefit of clear vision at multiple distances without the need for bifocals or reading glasses. Patients are also showing increased interest in surgical options such as LASIK or corneal inlays, which offer long-term correction and eliminate the daily hassle of managing eyewear. Additionally, as technology has advanced, many people now expect treatments to be minimally invasive with short recovery times, further pushing the development of sophisticated, low-risk surgical options for presbyopia correction.

Aesthetic concerns also play a significant role in patient preferences, particularly among younger generations who prioritize appearance and convenience. This has led to a growing interest in treatments that allow for clear vision without the visible use of glasses, making contact lenses, refractive surgeries, and innovative eye drop therapies increasingly popular. These shifting patient preferences are driving the demand for more diverse, customized, and less invasive treatment options for both myopia and presbyopia, fundamentally transforming the way these conditions are managed.

What Is Driving the Growth of the Global Myopia and Presbyopia Treatment Market?

The growth in the global myopia and presbyopia treatment market is being driven by several key factors, including the rising prevalence of these vision disorders, the increasing demand for advanced and minimally invasive treatments, and technological innovations in eye care. One of the most significant growth drivers is the sharp rise in myopia cases globally, particularly among younger populations in urban areas. Factors such as increased screen time, digital device usage, and reduced time spent outdoors are contributing to an epidemic of myopia, especially in Asia-Pacific, where some regions report myopia prevalence rates exceeding 80%. This has led to an urgent need for treatments that not only correct but also slow the progression of myopia, fueling demand for products like Ortho-K lenses, atropine eye drops, and advanced contact lenses.

Another key driver is the aging global population, which is contributing to a growing number of presbyopia cases. As life expectancy increases, more people are seeking effective treatments for presbyopia to maintain their quality of life and independence. This demographic trend has led to a surge in demand for presbyopia-correcting options such as multifocal intraocular lenses (IOLs), presbyopia-correcting contact lenses, and surgical solutions like LASIK. Additionally, the rise of cosmetic eye care and lifestyle-based treatments is encouraging individuals to opt for long-term solutions that enhance their vision without the need for glasses, further driving market growth.

Technological advancements in the diagnosis and treatment of myopia and presbyopia are also significant growth factors. Innovations such as AI-powered diagnostic tools, minimally invasive surgical techniques, and advanced lens designs are improving treatment outcomes and making these options more accessible to a wider range of patients. Furthermore, the increasing availability of telemedicine services is expanding access to eye care, particularly in remote and underserved regions, where traditional eye care services may be limited. This is expected to further boost the adoption of advanced treatments for myopia and presbyopia as more people gain access to specialized care.

Lastly, rising healthcare expenditure and improved awareness about vision health are contributing to market growth. Governments and healthcare organizations are increasingly recognizing the importance of early detection and treatment of refractive errors to prevent long-term vision problems, leading to greater investment in eye health services and public awareness campaigns. The combination of these factors—rising prevalence, aging populations, technological innovation, and greater access to care—is driving the rapid growth of the global myopia and presbyopia treatment market, positioning it for significant expansion in the coming years.

Select Competitors (Total 51 Featured) -

  • AbbVie, Inc.
  • Alcon, Inc.
  • Bausch & Lomb, Inc.
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • EssilorLuxottica
  • Eyenovia
  • Johnson & Johnson Vision Care, Inc.
  • LENZ Therapeutics
  • Ocuphire Pharma, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Myopia and Presbyopia Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Myopia and Presbyopia Propels Demand for Treatment Solutions
    • Case Overview: Innovation in Contact Lens Technology Bodes Well for Market Expansion
    • Growing Awareness of Early Detection and Treatment Sets the Stage for Myopia Management
    • Focus on Digital Eye Strain from Increased Screen Time Spurs Demand for Myopia Treatments
    • Case Overview: Growth in Aging Population Expands Demand for Presbyopia Treatments
    • Technological Advancements in Multifocal Intraocular Lenses Propel Growth in Presbyopia Market
    • Rising Consumer Focus on Aesthetic Vision Correction Solutions Spurs Demand for Surgery
    • Increasing Focus on Pediatric Myopia Management Expands Opportunities for Preventative Treatments
    • Development of Eye Drop Solutions for Myopia and Presbyopia Bodes Well for Market Innovation
    • Case Overview: Technological Advancements in LASIK and SMILE Procedures Propel Market Growth
    • Expansion of Telemedicine and Online Eye Care Services Expands Access to Treatment Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Myopia and Presbyopia Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Myopia and Presbyopia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Myopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Myopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Myopia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Presbyopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Presbyopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Presbyopia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • JAPAN
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • CHINA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • EUROPE
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Myopia and Presbyopia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • FRANCE
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • GERMANY
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Myopia and Presbyopia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • INDIA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Myopia and Presbyopia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Myopia and Presbyopia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • AFRICA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030

IV. COMPETITION